1,535
Views
2
CrossRef citations to date
0
Altmetric
Original Articles: Cancer Epidemiology

Prevalence of mental disorders in patients with cancer compared to matched controls – secondary analysis of two nationally representative surveys

ORCID Icon, , , ORCID Icon, , & show all
Pages 7-13 | Received 14 Jul 2021, Accepted 06 Oct 2021, Published online: 03 Nov 2021

Figures & data

Table 1. Demographic and disease-related characteristics of the cancer sample, unweighted (n = 2141).

Figure 1. Comparison of mental disorder prevalence rates in patients with cancer (n = 2141) vs. age and gender-matched general population controls (n = 4483). Prevalence rates in controls were weighted based on propensity score-matching. Matching accounted for age, gender, and age × gender interaction. 12-month-prevalence rates were assessed. *p < .05, **p < .01, and ***p < .001.

Figure 1. Comparison of mental disorder prevalence rates in patients with cancer (n = 2141) vs. age and gender-matched general population controls (n = 4483). Prevalence rates in controls were weighted based on propensity score-matching. Matching accounted for age, gender, and age × gender interaction. 12-month-prevalence rates were assessed. *p < .05, **p < .01, and ***p < .001.

Figure 2. Prevalence rates for any mental disorder (without nicotine dependence) in patients with cancer vs. age and gender-matched controls by demographic and disease-related subgroups. Each medical subgroup (e.g., breast cancer) is compared with accordingly matched non-cancer controls, i.e., breast cancer patients (left column) are compared with female controls of matching age (right column). Prevalence rates in controls were weighted based on propensity score-matching. Matching accounted for age, gender, and age × gender interaction. 12-month-prevalence rates were assessed. *p < .05, **p < .01, and ***p < .001.

Figure 2. Prevalence rates for any mental disorder (without nicotine dependence) in patients with cancer vs. age and gender-matched controls by demographic and disease-related subgroups. Each medical subgroup (e.g., breast cancer) is compared with accordingly matched non-cancer controls, i.e., breast cancer patients (left column) are compared with female controls of matching age (right column). Prevalence rates in controls were weighted based on propensity score-matching. Matching accounted for age, gender, and age × gender interaction. 12-month-prevalence rates were assessed. *p < .05, **p < .01, and ***p < .001.
Supplemental material

Supplemental Material

Download MS Word (848.7 KB)

Data availability statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.